MAR 23, 2018 4:44 PM PDT

Splenda may Exacerbate Symptoms of Crohn's Disease

WRITTEN BY: Carmen Leitch

For people with the intestinal disorder Crohn’s disease, Splenda might be a poor choice. Researchers using a mouse model looked at the effects of Sucralose intake over six weeks and saw that the artificial sweetener did not affect mice without a disease similar to Crohn’s. But in mice that had the disease, their gut inflammation got worse. Their work has been published in the journal Inflammatory Bowel Diseases.

"Our findings suggest that patients with Crohn's disease should think carefully about consuming Splenda or similar products containing sucralose and maltodextrin," said the lead author of the work Dr. Alex Rodriguez-Palacios, an assistant professor of medicine at Case Western Reserve School of Medicine. "Several studies have examined the ingredients found in this widely available product, separately."

Splenda, a blend of maltodextrin and Sucralose, was brought to the market in 1992 by Heartland Consumer Products. It has been called 600 times sweeter than sugar, and more than 100 billion packets have been sold.

About 1.3 percent of Americans have some form of inflammatory bowel disease, of which Crohn's disease is one type. Affecting the digestive tract, it might include weight loss, fatigue, cramping, severe diarrhea, and bloody stools.

"This is perhaps the closest we can get to provide experimental evidence that these ingredients together induce biological changes known to cause inflammation which could be harmful over time to susceptible animal subjects," Rodriguez-Palacios said. "Our next step would be to run experiments directly in patients, but that is more difficult to conduct given the large variability that is inherent to human genetics, microbiome, and diet."

In the mice modeling Crohn's disease, there were more Proteobacteria compared to the healthy mice. Proteobacteria include microbes like E. coli and salmonella and were found in the intestines of mice that were consuming water spiked Splenda. A molecule called myeloperoxidase that has an anti-microbial effect was also found at higher levels in mice that drank Splenda.

People with Crohn's disease might want to skip the Splenda. / Image credit: Pixabay

"This study demonstrates that the sweetener induces changes in gut bacteria and gut wall immune cell reactivity, which could result in inflammation or disease flare-ups in susceptible people," Rodriguez-Palacios said. "On the other hand, the study suggests that individuals free of intestinal diseases may not need to be overly concerned."

Although there may be many reasons for chronic inflammation, the researchers suggested that it is possible that other artificial ingredients are impacting chronic conditions like Crohn's disease.

"This suggests that other dietary habits or additives may lead to similar microbiota alterations," said senior author Dr. Fabio Cominelli, a professor of medicine at Case Western Reserve School of Medicine and chief of gastroenterology at Cleveland Medical Center. "For instance, diet emulsifiers used as food additives have also been shown recently to alter the gut microbiota and promote colitis in mice.

"Other scenarios could put Crohn's disease patients at risk of having exaggerated inflammation as well," he added. "This could include unexpected foodborne bacterial infections which would further recruit myeloperoxidase-containing leukocytes to the intestinal tract and the resultant inflammation."


Sources: UPI, Case Western Reserve UniversityInflammatory Bowel Diseases

About the Author
BS
Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 14, 2022
Chemistry & Physics
The Precursor to ATP
OCT 14, 2022
The Precursor to ATP
  Adenosine triphosphate (ATP) is the essential energy molecule that drives our bodies. The cleavage of one of its ...
OCT 14, 2022
Drug Discovery & Development
Experimental Gene Therapy Restores Night Vision in Blind Patients
OCT 14, 2022
Experimental Gene Therapy Restores Night Vision in Blind Patients
Adults with a hereditary form of childhood-onset blindness experienced dramatic improvements in night vision within days ...
NOV 06, 2022
Genetics & Genomics
The Lone Participant in a CRISPR Therapy Trial has Died
NOV 06, 2022
The Lone Participant in a CRISPR Therapy Trial has Died
In August of this year, a single patient was enrolled in a trial that used CRISPR to correct a genetic mutation that led ...
NOV 09, 2022
Genetics & Genomics
Want to Study Copy Number Alterations in Cells? Bring MACHETE
NOV 09, 2022
Want to Study Copy Number Alterations in Cells? Bring MACHETE
Sure, MACHETE is a cool name, but the researchers that developed the technique are hoping people don't focus solely on t ...
NOV 11, 2022
Health & Medicine
The Biomarker That Could Help Predict Disease in Men
NOV 11, 2022
The Biomarker That Could Help Predict Disease in Men
The role of a crucial hormone called INSL3 (insulin-like peptide hormone) has been discovered, and it may help predict w ...
NOV 17, 2022
Plants & Animals
Creating living cells from dead Sumatran rhinoceros' tissue
NOV 17, 2022
Creating living cells from dead Sumatran rhinoceros' tissue
The Sumatran rhinoceros are considered a critically endangered species, with an estimated 80 or fewer Sumatran rhinos al ...
Loading Comments...